Skip to content

NuSkin Enterprises NUS Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Kenvue logo
KenvueKVUE
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's treasury stock, shares (in shares)?
NuSkin Enterprises (NUS) reported treasury stock, shares (in shares) of $42M in Q1 2026.
How has NuSkin Enterprises's treasury stock, shares (in shares) changed year-over-year?
NuSkin Enterprises's treasury stock, shares (in shares) increased by 1.9% year-over-year, from $41.2M to $42M.
What is the long-term trend for NuSkin Enterprises's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), NuSkin Enterprises's treasury stock, shares (in shares) has grown at a 1.0% compound annual growth rate (CAGR), from $40.7M to $42.4M.